Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 1/20 | 0.52 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.52 |
| ▸ | DHODH | Q02127 | 1/20 | 0.49 |
| ▸ | SCN9A | Q15858 | 5/20 | 0.45 |
| ▸ | RORC | P51449 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.43 |
| ▸ | CTSA | P10619 | 2/20 | 0.42 |
| ▸ | MYC | P01106 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL240363 | 0.81 | FABP4 (0.49) | FABP4FABP5DHODHSCN9ARORC | |
| SCHEMBL13601647 | 0.80 | ACMSD (0.50) | DHODHALDH1A1MYC | |
| SCHEMBL13601588 | 0.80 | AKR1C3 (0.50) | DHODHSCN9AALDH1A1MYC | |
| SCHEMBL13601639 | 0.78 | S1PR1 (0.50) | FABP4FABP5SCN9ARORCALDH1A1 | |
| SCHEMBL28500487 | 0.78 | PTGER1 (0.59) | FABP4FABP5DHODHSCN9ARORC | |
| SCHEMBL13601657 | 0.76 | MYC (0.42) | DHODHSCN9AMYC | |
| SCHEMBL13601631 | 0.75 | LDHA (0.49) | DHODHSCN9AALDH1A1MYC | |
| SCHEMBL13601658 | 0.75 | TAS2R14 (0.42) | DHODHSCN9AMYC | |
| SCHEMBL13601650 | 0.75 | DHODH (0.47) | DHODHALDH1A1MYC | |
| SCHEMBL28680311 | 0.74 | ACLY (0.42) | DHODHSCN9AALDH1A1S1PR1CTSA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090298894-A1 | AMINO ACID COMPOUNDS | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-12-03 | — | — | US | disclosed |
| US-20090298894-A1 | AMINO ACID COMPOUNDS | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090298894-A1 | AMINO ACID COMPOUNDS | S1PR1, S1PR2, S1PR5 | FABP4 1986/4885FABP5 1197/4885DHODH 2603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.